Company · Ownership research

TREACE MEDICAL CONCEPTS, INC. TMCI

CIK 0001630627

Form 4 transactions dated Nov 1, 2023 to Nov 10, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 43 rows; the complete set is available through the API.

Insider filings on file run through Oct 28, 2026.

Insider purchases & sales

Purchased: $9.07M
Sold: $398.46K

Nov 1, 2023 – Oct 28, 2026
Available records · partial months are marked ·

202410 of 20 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Sep 16, 2024	Treace John T. Chief Executive Officer · Director · 10% owner	Purchase	$265.63K 50,000 shares bought	0.77% added Direct holding	▾
Aug 15, 2024	TREACE JAMES T Director	Purchase	$501.03K 84,000 shares bought	7.37% added Direct holding	▾
Aug 14, 2024	Treace John T. Chief Executive Officer · Director · 10% owner	Purchase	$510.31K 85,000 shares bought	1.33% added Direct holding	▾
Jun 11, 2024	Treace John T. Chief Executive Officer · Director · 10% owner	Purchase	$264.60K 45,000 shares bought	0.71% added Direct holding	▾
May 31, 2024	TREACE JAMES T Director	Purchase	$151.33K 25,000 shares bought	2.24% added Direct holding	▾
May 29, 2024	TREACE JAMES T Director	Purchase	$130.06K 25,000 shares bought	2.29% added Direct holding	▾
May 28, 2024	TREACE JAMES T Director	Purchase	$253.47K 50,000 shares bought	4.81% added Direct holding	▾
May 24, 2024	MOTT RICHARD W Director	Purchase	$93.50K 18,000 shares bought	1.71% added Direct holding	▾
May 22, 2024	MOTT RICHARD W Director	Purchase	$60.42K 12,100 shares bought	1.16% added Direct holding	▾
May 17, 2024	Treace John T. Chief Executive Officer · Director · 10% owner	Purchase	$556.17K 100,000 shares bought	1.60% added Direct holding	▾

Showing 20 / 20 record groups in 2024. The complete set is available through the API.

TREACE MEDICAL CONCEPTS, INC. · TMCI

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 20 of 20 purchase / sale groups and 30 of 43 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"TMCI","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.